Treatment strategies currently trialled for patients with depression presenting with increased inflammation include the use of anti-inflammatory medications, such as minocycline and tumor necrosis factor (TNF)-alpha inhibitors [55]. This evidence concerns the gene TNF and major depressive disorder.